IP Library Granted Patent US 7,720,694
Granted Patent B2
US 7,720,694 · App. 11/609,443 · Granted May 18, 2010

Pharmaceutical verification network

Assignee: Optopo Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,720,694
App. No.
11/609,443
Granted
May 18, 2010
Kind
B2
Abstract

Embodiments of the present invention relate to systems and methods for communicating pharmaceutical verification information between a server and a node using a network. A node includes a pharmaceutical identification and verification system. The verification information includes a known spectral signature of a known pharmaceutical and a corresponding known pharmaceutical name and dosage strength of the known pharmaceutical. The server stores the verification information in a server database. The node receives the verification information from the server, stores the verification information in the client database, reads a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical, obtains a detected spectral signature for the pharmaceutical, and compares the detected spectral signature to the at least one known spectral signature. The pharmaceutical identification and verification system includes a static multimodal multiplex spectrometer. The verification information can also include a spectral signature of a known container.

Claims (79)

1. A system for communicating pharmaceutical verification information, the system comprising:

a network;

a server database;

a server connected to the network and the server database, the server storing at least one known spectral signature of a known pharmaceutical and a corresponding known pharmaceutical name and dosage strength of the known pharmaceutical in the server database;

a client database; and

a pharmaceutical identification and verification system connected to the network and the client database, the pharmaceutical identification and verification system comprising a static multimode multiplex spectrometer and being capable of receiving the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength from the server, storing the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength in the client database, reading a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical, obtaining a detected spectral signature for the pharmaceutical by performing an analysis of the pharmaceutical through the container, and comparing the detected spectral signature to the at least one known spectral signature.

2. The system of claim 1 , wherein if the detected spectral signature matches the at least one known spectral signature, the pharmaceutical identification and verification system compares the pharmaceutical name and dosage strength to the known pharmaceutical name and dosage strength to verify the pharmaceutical.

3. The system of claim 2 , wherein the pharmaceutical identification and verification system sends a signal to the server each time it obtains a spectral signature that is not verified.

4. The system of claim 1 , wherein the container comprises one of a prescription vial, a manufacturer's bottle, and a wholesaler's bottle.

5. The system of claim 1 , wherein if the detected spectral signature does not correspond to any spectral signatures in the client database, the pharmaceutical identification and verification system sends the detected spectral signature to the server.

6. The system of claim 5 , wherein if the detected spectral signature does not correspond to any spectral signatures in the client database, the pharmaceutical identification and verification system sends a pharmaceutical name and dosage strength read from the container to the server.

7. The system of claim 1 , wherein the pharmaceutical identification and verification system sends a transaction record to the server each time it obtains a spectral signature for a pharmaceutical.

8. The system of claim 1 , wherein the server sends an update of the at least one known spectral signature to the pharmaceutical identification and verification system.

9. The system of claim 1 , wherein the at least one known spectral signature comprises a spectral signature of a known container and the detected spectral signature comprises a spectral signature of the container.

10. The system of claim 1 , wherein the detected spectral signature is produced by the static multimode multiplex spectrometer and the at least one known spectral signature is produced by a second static multimode multiplex spectrometer.

11. A method for communicating pharmaceutical verification information between a server and a pharmaceutical identification and verification system, the method comprising:

the server storing at least one known spectral signature of a known pharmaceutical and a corresponding known pharmaceutical name and dosage strength of the known pharmaceutical in a server database connected to the server, the server being connected to a network;

the pharmaceutical identification and verification system receiving the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength from the sewer, the pharmaceutical identification and verification system being connected to the network and a client database and comprising a static multimode multiplex spectrometer;

the pharmaceutical identification and verification system storing the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength in the client database;

the pharmaceutical identification and verification system reading a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical;

the pharmaceutical identification and verification system obtaining a detected spectral signature for the pharmaceutical by performing an analysis of the pharmaceutical through the container; and

the pharmaceutical identification and verification system comparing the detected spectral signature to the at least one known spectral signature.

12. The method of claim 11 , wherein the at least one known spectral signature comprises a spectral signature of a known container and the detected spectral signature comprises a spectral signature of the container.

13. The method of claim 11 , wherein the detected spectral signature is produced by the static multimode multiplex spectrometer and the at least one known spectral signature is produced by a second static multimode multiplex spectrometer.

14. A system for communicating pharmaceutical verification information, the system comprising:

a network;

a server database;

a server connected to the network and the server database, the server storing at least one known spectral signature comprising a spectral signature of a known pharmaceutical and a spectral signature of a known container in the server database and storing a corresponding known pharmaceutical name and dosage strength of the known pharmaceutical in the sewer database;

a client database; and

a pharmaceutical identification and verification system connected to the network and the client database, the pharmaceutical identification and verification system being capable of receiving the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength from the server, storing the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength in the client database, reading a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical, obtaining a detected spectral signature comprising a spectral signature of the pharmaceutical and a spectral signature of the container by performing an analysis of the pharmaceutical through the container, and comparing the detected spectral signature to the at least one known spectral signature.

15. A method for communicating pharmaceutical verification information between a server and a pharmaceutical identification and verification system, the method comprising:

the server storing at least one known spectral signature comprising a spectral signature of a known pharmaceutical and a spectral signature of a known container and a corresponding known pharmaceutical name and dosage strength of the known pharmaceutical in a server database connected to the sewer, the server being connected to a network;

the pharmaceutical identification and verification system receiving the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength from the sewer, the pharmaceutical identification and verification system being connected to the network and a client database;

the pharmaceutical identification and verification system storing the at least one known spectral signature and the corresponding known pharmaceutical name and dosage strength in the client database;

the pharmaceutical identification and verification system reading a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical;

the pharmaceutical identification and verification system obtaining a detected spectral signature comprising a spectral signature of the pharmaceutical and a spectral signature of the container by performing an analysis of the pharmaceutical through the container; and

the pharmaceutical identification and verification system comparing the detected spectral signature to the at least one known spectral signature.

16. A system for communicating pharmaceutical verification information, the system comprising:

a network;

a pharmaceutical identification and verification system connected to the network, the pharmaceutical identification and verification system comprising a static multimode multiplex spectrometer and being capable of reading a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical and obtaining a detected spectral signature for the pharmaceutical by performing an analysis of the pharmaceutical through the container;

a server database; and

a server connected to the network and the server database, the server being capable of receiving the pharmaceutical name and dosage strength and the detected spectral signature from the pharmaceutical identification and verification system, comparing the detected spectral signature to one or more known spectral signatures of known pharmaceuticals in the server database to determine an identity of the pharmaceutical, comparing a known pharmaceutical name and dosage strength corresponding to a known spectral signature of a known pharmaceutical that matches the detected spectral signature to the pharmaceutical name and dosage strength to verify the pharmaceutical, and sending a result of the verification to the pharmaceutical identification and verification system.

17. The system of claim 16 , wherein the container comprises one of a prescription vial, a manufacturer's bottle, and a wholesaler's bottle.

18. The system of claim 16 , wherein the known spectral signature comprises a spectral signature of a known container and the detected spectral signature comprises a spectral signature of the container.

19. The system of claim 16 , wherein the server records each detected spectral signature that is not verified.

20. A method for communicating pharmaceutical verification information between a server and a pharmaceutical identification and verification system, the method comprising:

the pharmaceutical identification and verification system reading a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical, the pharmaceutical identification and verification system being connected to a network and comprising a static multimode multiplex spectrometer;

the pharmaceutical identification and verification system obtaining a detected spectral signature for the pharmaceutical by performing an analysis of the pharmaceutical through the container;

the server receiving the pharmaceutical name and dosage strength and the detected spectral signature from the pharmaceutical identification and verification system, the server being connected to the network and a server database;

the server comparing the detected spectral signature to one or more known spectral signatures of known pharmaceuticals in the server database to determine an identity of the pharmaceutical;

the server comparing a known pharmaceutical name and dosage strength corresponding to a known spectral signature of a known pharmaceutical that matches the detected spectral signature to the pharmaceutical name and dosage strength to verify the pharmaceutical; and

the server sending a result of the verification to the pharmaceutical identification and verification system.

21. The method of claim 20 , wherein the known spectral signature comprises a spectral signature of a known container and the detected spectral signature comprises a spectral signature of the container.

22. The method of claim 20 , further comprising the server recording each detected spectral signature that is not verified.

23. A system for communicating pharmaceutical verification information, the system comprising:

a network;

a pharmaceutical identification and verification system connected to the network, the pharmaceutical identification and verification system being capable of reading a pharmaceutical name and dosage strength of a prescription from a container enclosing a pharmaceutical and obtaining a detected spectral signature by performing an analysis of the pharmaceutical through the container, the detected spectral signature comprising a spectral signature of the pharmaceutical and a spectral signature of the container;

a server database; and

a server connected to the network and the server database, the server being capable of receiving the pharmaceutical name and dosage strength and the detected spectral signature from the pharmaceutical identification and verification system, comparing the detected spectral signature to one or more known spectral signatures in the sewer database to determine an identity of the pharmaceutical, comparing a known pharmaceutical name and dosage strength corresponding to a known spectral signature that matches the detected spectral signature to the pharmaceutical name and dosage strength to verify the pharmaceutical, and sending a result of the verification to the pharmaceutical identification and verification system, each of the one or more known spectral signatures comprising a spectral signature of a known pharmaceutical and a spectral signature of a known container.

24. The system of claim 23 , wherein the server records each detected spectral signature that is not verified in the server database.

25. A method for communicating pharmaceutical verification information between a server and a pharmaceutical identification and verification system, the method comprising:

the pharmaceutical identification and verification system reading a pharmaceutical name and dosage strength of a prescription from a container enclosing a pharmaceutical, the pharmaceutical identification and verification system being connected to a network;

the pharmaceutical identification and verification system obtaining a detected spectral signature by performing an analysis of the pharmaceutical through the container, the detected spectral signature comprising a spectral signature of the pharmaceutical and a spectral signature of the container;

the server receiving the pharmaceutical name and dosage strength and the detected spectral signature from the pharmaceutical identification and verification system, the server being connected to the network and a server database;

the server comparing the detected spectral signature to one or more known spectral signatures in the server database to determine an identity of the pharmaceutical, each of the one or more known spectral signatures comprising a spectral signature of a known pharmaceutical and a spectral signature of a known container;

the server comparing a known pharmaceutical name and dosage strength corresponding to a known spectral signature that matches the detected spectral signature to the pharmaceutical name and dosage strength to verify the pharmaceutical; and

the server sending a result of the verification to the pharmaceutical identification and verification system.

26. The system of claim 25 , further comprising the sewer recording each detected spectral signature that is not verified in the server database.

27. A method for distributing pharmaceutical verification information from a central sewer of a data provider to a pharmaceutical identification and verification system at a customer's location, the method comprising:

downloading the pharmaceutical verification information from the central server to a portable media device;

sending the portable media device to the customer's location; and

uploading the pharmaceutical verification information from the portable media device to the pharmaceutical identification and verification system wherein the pharmaceutical verification information comprises at least one known spectral signature of a known pharmaceutical obtained by performing an analysis of the pharmaceutical through a container.

28. The method of claim 27 , wherein the pharmaceutical verification information comprises a known pharmaceutical name and dosage strength of the known pharmaceutical.

29. The method of claim 28 , wherein the at least one known spectral signature comprises a spectral signature of a known pharmaceutical container.

30. The method of claim 29 , wherein the known pharmaceutical container comprises one of a prescription vial, a manufacturer's bottle, and a wholesaler's bottle.

31. The method of claim 28 , wherein the at least one known spectral signal is produced by a static multimode multiplex spectrometer.

32. The method of claim 27 , wherein the pharmaceutical identification and verification system comprises a static multimode multiplex spectrometer.

33. The method of claim 27 , where the portable media device comprises one of a compact disc read-only memory, a floppy disk, a magnetic tape, a flash memory drive, a flash memory card, a firmware device, a thumb-drive, and a universal serial bus drive.

34. The method of claim 27 , wherein sending the portable media device to the customer's location comprises mailing the portable media device to the customer's location.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: READSBORO INTERNATIONAL CORPORATION
To: ASB INTERNATIONAL SERVICES LTD
Reel/Frame 055638/0474 →
SUPPLEMENT TO RESUBMISSION DOC ID 504060101 Recorded Feb 7, 2017
From: CENTICE CORPORATION F/K/A/ OPTOPO INC.
To: READSBORO INTERNATIONAL CORPORATION
Reel/Frame 041650/0055 →
STRICT FORECLOSURE RESULTING FROM PROMISSORY NOTE DEFAULT Recorded Oct 20, 2016
From: CENTICE CORPORATION F/K/A OPTOPO INC.
To: READSBORO INTERNATIONAL CORPORATION
Reel/Frame 041190/0466 →
RELEASE OF SECURITY INTEREST Recorded May 14, 2013
From: FULCRUM FINANCIAL PARTNERS, L.P. AND OSCRIVIA LIMITED
To: CENTICE CORPORATION
Reel/Frame 030410/0175 →
RELEASE OF SECURITY INTEREST Recorded Apr 16, 2012
From: CENTICE CORPORATION
To: VOGEN FUNDING, L.P.
Reel/Frame 028052/0668 →
SECURITY AGREEMENT Recorded Apr 11, 2012
From: CENTICE CORPORATION
To: OSCRIVIA LIMITED; FULCRUM FINANCIAL PARTNERS, L.P.
Reel/Frame 028026/0275 →
SECURITY AGREEMENT Recorded Jun 11, 2008
From: CENTICE CORPORATION
To: VOGEN FUNDING, L.P.
Reel/Frame 021194/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2007
From: POTULURI, PRASANT, DR.; BRADY, DAVID J., DR.; FULLER, MICHAEL
To: OPTOPO INC., D/B/A CENTICE CORPORATION
Reel/Frame 020122/0321 →
Continuity (8)
Continuation In Part 1145492300 · Jun 19, 2006
Continuation In Part 1133454600 · Jan 19, 2006
Continuation In Part 1041706600 · Apr 16, 2003
Provisional Application 6064452200 · Jan 19, 2005
Provisional Application 6070517300 · Aug 4, 2005
Provisional Application 6072531100 · Oct 12, 2005
Provisional Application 6081110100 · Jun 6, 2006
Related Publication 20080059240A1 · Mar 6, 2008